SCHEMBL3047268

SCHEMBL3047268

O=C1NCc2ccnc(-c3cc4cc(CN5CCCCC5)ccc4[nH]3)c21

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 2/20 0.53
▸ KDR P35968 2/20 0.53
▸ CHEK1 O14757 18/20 0.52
▸ CDK7 P50613 6/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3149721 0.91 AURKA (0.44) AURKAKDRCHEK1CDK7
SCHEMBL3054503 0.86 CHEK1 (0.50) AURKAKDRCHEK1CDK7
SCHEMBL3051407 0.83 CHEK1 (0.49) AURKAKDRCHEK1CDK7
Hydrochloric Acid SCHEMBL3046615 0.82 AURKA (0.68) AURKAKDRCHEK1
SCHEMBL3837181 0.80 CHEK1 (0.56) AURKAKDRCHEK1CDK7
SCHEMBL3839156 0.79 CHEK1 (0.56) AURKAKDRCHEK1CDK7
SCHEMBL3839022 0.79 CHEK1 (0.63) AURKAKDRCHEK1CDK7
SCHEMBL3158228 0.76 CHEK1 (0.45) AURKAKDRCHEK1CDK7
SCHEMBL3047766 0.75 CHEK1 (0.55) AURKAKDRCHEK1CDK7
Hydrochloric Acid SCHEMBL3048533 0.74 CHEK1 (0.54) AURKAKDRCHEK1CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 — — US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 — — US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 AURKA 2312/4885KDR 3226/4885CHEK1 3306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback